Mana Capital provides investor presentation for proposed Cardio Diagnostics merger

Cardio Diagnostics Holdings, Inc.

Investor presentation first made available on August 26, 2022, for the business combination with Cardio Diagnostics.
Merger Agreement entered May 27, 2022; Cardio to become wholly owned subsidiary of Mana, renamed Cardio Diagnostics Holdings Inc.
Presentation will be used to solicit stockholder approval; Form S-4 proxy/prospectus filed with SEC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.